MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/1129729820932425

Медицинская библиотека · The journal of vascular access · 2020

Dual-chambered venous access port as alternative access for extracorporeal apheresis therapy.

Michell Hans, Nezami Nariman, Morris Christopher, Hong Kelvin

СтатьяПеревод в очереди

Аннотация

PURPOSE: To evaluate the use of a dual-chambered venous access port for extracorporeal apheresis therapy.

METHODS

This was a single-center retrospective analysis of all patients who received a dual-chambered venous access port for apheresis therapy over a 36-month period. Clinical success was defined as successful completion of at least one round of apheresis via the venous access port. Major complications were defined as any event requiring elevation of patient care and/or venous access port removal or repositioning. Minor complications were defined as venous access port issues resolved with clinical intervention.

RESULTS

Forty-four patients had a venous access port placed at the time of this study. Patients underwent red cell exchange (n = 33), therapeutic plasma exchange (n = 6) or extracorporeal photopheresis (n = 5). Forty (90%) patients had autoimmune diseases and four (10%) had neoplastic processes. Clinical success was achieved in 42 (95.5%) patients. Average venous access port dwell time was 632 days (range = 42-1191 days). All therapies through the venous access ports were well tolerated and no patients reported pain or discomfort. Major complications were seen in nine (20.5%) patients-the majority (n = 7) of which were due to venous access port malfunction-and resolved with catheter revision. One (2.27%) major complication involved an infected venous access port, and one involved a large hematoma at the venous access port site. Minor complications were seen in eight (18.2%) patients, where simple flushing of the catheter with saline or tissue plasminogen activator resolved the issue.

CONCLUSION

The dual-chambered venous access port was successfully used for sustained blood flow in apheresis therapy with a moderate, yet correctable complication rate.

Для цитирования: Michell Hans, Nezami Nariman, Morris Christopher, Hong Kelvin. Dual-chambered venous access port as alternative access for extracorporeal apheresis therapy.. The journal of vascular access. 2020. DOI: 10.1177/1129729820932425.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.